HCA Healthcare, Inc. 4

Director William R. Frist received an award of 809 restricted share units of HCA Healthcare, Inc. common stock as part of his annual director compensation.

On April 28, 2026, William R. Frist, a director of HCA Healthcare, Inc., received an automatic grant of 809 restricted share units (RSUs) of HCA common stock, consisting of 509 RSUs attributable to an annual director equity award and 300 RSUs received in lieu of an annual cash retainer. The transaction is reported as an acquisition at no cash cost to the insider, with the RSUs scheduled to vest on the earlier of the 2027 annual shareholders' meeting or the first anniversary of the grant date, and the underlying shares to be delivered when he ceases serving on the Board. After this award, he is shown as directly holding 13,740 shares, and also having large indirect interests via Frisco Holding II (36,557,141 shares), Hercules Holding II (32,282,889 shares), as well as smaller indirect holdings through his spouse and children (1,416 shares), trusts (340,852 shares), and family partnerships (60,678 shares, all figures reflecting forms of indirect beneficial interests). Based on HCA’s indicative share price of about $430, the newly granted RSUs are worth roughly $347,870 and his direct holdings are worth about $5.9 million, with his reported indirect vehicles collectively controlling tens of millions of additional shares, although he disclaims beneficial ownership except to the extent of his pecuniary interest.

Filing Facts

CIK

860730

Ticker

HCA

Form

4

Source Type

sec

Accession

0001140361-26-018355

Alert Tier

5